Alzheimer's disease with dementia
Pro Research Analysisby 
Searched over 200M research papers
Alzheimer's Disease with Dementia: An Overview
Introduction to Alzheimer's Disease and Dementia
Alzheimer's disease (AD) is the most common cause of dementia, a condition characterized by a progressive decline in cognitive function and memory, leading to a loss of independence in daily activities 124. The global prevalence of dementia is estimated to be around 24 million, with Alzheimer's disease accounting for the majority of these cases 89. This neurodegenerative disease poses a significant public health concern due to its growing incidence and the substantial burden it places on individuals and society 19.
Pathology and Pathogenesis of Alzheimer's Disease
The hallmark pathological features of Alzheimer's disease include the accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles composed of hyperphosphorylated tau protein 5710. These pathological changes lead to neuronal loss, synaptic dysfunction, and ultimately, cognitive decline 57. The exact mechanisms driving these changes remain unclear, but they are believed to involve a combination of genetic, environmental, and lifestyle factors 28.
Clinical Presentation and Diagnosis
Alzheimer's disease typically presents with an insidious onset and progressive impairment of memory and other cognitive functions 36. Early in the disease, there are no motor, sensory, or coordination deficits, which helps differentiate it from other forms of dementia 36. Diagnosis is primarily clinical, supported by neuropsychological tests and, increasingly, by fluid and imaging biomarkers 378. However, definitive diagnosis still relies on the identification of amyloid plaques and neurofibrillary tangles, often post-mortem 57.
Current Treatment Strategies
Currently, there are no treatments that can cure or prevent Alzheimer's disease. Available therapies, including cholinesterase inhibitors and NMDA receptor antagonists, are aimed at alleviating symptoms rather than modifying the disease course 2410. Nonpharmacological interventions, such as cognitive therapy and lifestyle modifications, also play a crucial role in managing the disease .
Emerging Therapeutic Approaches
Research is ongoing to develop disease-modifying therapies (DMTs) that target the underlying pathophysiological mechanisms of Alzheimer's disease. These include approaches aimed at reducing amyloid plaque formation, preventing tau protein aggregation, and addressing neuroinflammation and oxidative stress 247. Clinical trials are currently underway to evaluate the efficacy of these potential treatments .
Conclusion
Alzheimer's disease remains a major challenge in the field of neurodegenerative disorders, with significant implications for affected individuals and their caregivers. While current treatments provide symptomatic relief, there is an urgent need for therapies that can alter the disease's progression. Continued research into the pathogenesis and potential therapeutic targets of Alzheimer's disease is essential for developing effective interventions and improving patient outcomes.
Sources and full results
Most relevant research papers on this topic